Caxton Corporation’s KALA BIO KALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-5
Closed -$16K 40
2021
Q4
$16K Sell
5
-687
-99% -$3.19M 0.01% 50
2021
Q3
$4.53M Buy
692
+9
+1% +$77.7K 3.67% 8
2021
Q2
$9.04M Buy
683
+110
+19% +$1.73M 6.19% 6
2021
Q1
$9.64M Buy
573
+116
+25% +$2.26M 6.26% 6
2020
Q4
$7.75M Buy
457
+148
+48% +$2.78M 4.83% 7
2020
Q3
$5.79M Buy
309
+61
+25% +$1.4M 5.46% 6
2020
Q2
$6.52M Sell
248
-487
-66% -$13.8M 6.88% 5
2020
Q1
$16.1M Buy
735
+141
+24% +$2.25M 17.64% 2
2019
Q4
$5.47M Hold
594
5.28% 7
2019
Q3
$5.64M Sell
594
-8
-1% -$97.4K 6.36% 6
2019
Q2
$9.6M Buy
602
+1
+0.2% +$16.6K 10.9% 3
2019
Q1
$12.4M Buy
601
+57
+10% +$1.01M 11.52% 2
2018
Q4
$6.64M Buy
544
+523
+2,490% +$9.07M 8.05% 4
2018
Q3
$506K Buy
+21
New +$640K 0.47% 17
2018
Q1
Sell
-218
Closed -$10.1M 25
2017
Q4
$10.1M Hold
218
12.23% 3
2017
Q3
$12.4M Buy
+218
New +$12M 12.65% 3

Other funds holding KALA

Caxton Corporation's KALA Position: Q1 2022 in Review

Caxton Corporation sold out of KALA BIO (KALA) in Q1 2022, closing a stake of 5 shares — an estimated $16K sold.

Caxton Corporation first reported a position in KALA in Q3 2017 and held it in 16 quarters. The position peaked at $16.1M in Q1 2020. 82 funds tracked by Wall St. Rank hold KALA as of Q1 2022.

  • Caxton Corporation reported no remaining KALA BIO position as of Q1 2022 after selling out during the quarter.
  • Caxton Corporation sold 5 KALA BIO shares in Q1 2022, an estimated $16K.
  • Caxton Corporation first reported a position in KALA BIO in Q3 2017 and held it in 16 quarters.
  • Caxton Corporation's KALA BIO position peaked at $16.1M in Q1 2020.
  • 82 funds tracked by Wall St. Rank held KALA BIO as of Q1 2022.

Based on Caxton Corporation's 13F filing for Q1 2022, filed 16 May 2022.